Add Company
Join Now

Epsilogen Ltd Revenue and Competitors

License our Company Data API

London, London

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Epsilogen Ltd's estimated annual revenue is currently $2.2M per year.(i)
  • Epsilogen Ltd's estimated revenue per employee is $77,500

Employee Data

  • Epsilogen Ltd has 29 Employees.(i)
  • Epsilogen Ltd grew their employee count by 61% last year.

Epsilogen Ltd's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Senior ImmunologistReveal Email/Phone
5
Senior ScientistReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Principal ScientistReveal Email/Phone
8
Senior ScientistReveal Email/Phone
9
Phage Display ScientistReveal Email/Phone
10
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M1623%N/AN/A
#2
$11.8M7621%N/AN/A
#3
$1.8M2335%N/AN/A
#4
$2.2M2961%N/AN/A
#5
$1.8M2335%N/AN/A
#6
$0.9M129%N/AN/A
#7
$0.1M10%N/AN/A
#8
$18.3M118-3%N/AN/A
#9
$0.5M620%N/AN/A
#10
$4.8M6241%N/AN/A
Add Company

What Is Epsilogen Ltd?

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$2.2M

Revenue (est)

61%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M29-12%N/A
#2
$4.6M29-6%N/A
#3
$2.9M29-17%N/A
#4
N/A29-24%N/A
#5
$2.4M29-59%N/A